Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
bet they wish they sold this week!
Only 10k shares but they cost me 4.8k - still a good cgt loss -Doh!
Oh! and congrats!! Must be nice to have an RNS dedicated to one's self! I've also been chasing HLO to the bottom - similar story on contracts...
You're very brave.. I'm waiting for a tsunami of contracts being signed before I commit more funds - I'm going to sell my original stake after 30 days elapsed from last purchase to capitalise on lossess then my average will be around 8 and I can build on that after a further 30 days have elapsed from that sell. So 2 months to go for me!!
However, no guarantee can be provided until the Company is able to ascertain the quantum of the fundraising needed and any terms on which such fundraising could be undertaken. A further update will be made in due course.
In this regard the Board has approached its two substantial shareholders to ascertain their appetite to provide additional capital to the Company and, while these discussions are on-going, they have indicated that they are supportive of the business going forward.
ZZzzzzzzz Till Next prelim announcement 07/03/2013 Next annual report due 31/03/2013
look at the amount of small trades today - a sudden burst of buying activity for no apparent reason. What's up Doc?
don't you ever bother to read previous posts???
Bought another 30k and brought my average down to 15.57p from double that, can't see it going anywhere but up after sitting at these lows and price should start to move once contracts are put to bed...
Avia Health Infrmtcs Plain Healthcare awarded NICE Accreditation RNS Number : 4924W Avia Health Informatics PLC 28 January 2013  28 January 2013 Avia Health Informatics Plc ("Avia" or the "Company") Plain Healthcare awarded NICE Accreditation Avia (AIM: AVIA), the developer and provider of clinical decision support and referral facilitation software, via its wholly owned subsidiary, Plain Healthcare, announces that it has achieved National Institute for Health and Clinical Excellence ("NICE") accreditation for its approach to developing and maintaining the content in its Odyssey clinical decision support system. Following a thorough appraisal of Plain Healthcare's clinical development processes, the NICE Accreditation Advisory Committee has commended the Company for the robust and systematic methods used for searching and identifying the evidence base used to populate the Odyssey clinical database. This database is used by Odyssey to guide the assessment and interpretation of symptoms during primary care consultations with patients and the provision of advice and information. The Odyssey suite of products has been designed specifically to address the needs of the modern NHS. Avia's expert clinical team has developed a robust product which not only improves processes and provides access to local pathways but also makes significant savings in both time and money. Dr Carl Parker, Vice Chair, Accreditation Advisory Committee, congratulated Plain Healthcare on achieving this excellent standard of content development and assisting in validating this approach to the quality assurance of content used in decision support. Professor Jeremy Dale, Chief Executive of Avia Health Informatics Plc, commented: "We are delighted that Plain Healthcare has achieved NICE accreditation. This is testament to the safety and effectiveness of Odyssey clinical content and the hard work and commitment of our clinical team. We are committed to continuously reviewing and improving our processes to ensure the highest of standards. NICE accreditation provides validation that will be welcomed by patients, clinicians and managers of services that use Odyssey decision support."
seems to be a general malaise in the health industry at the moment, due to delays caused by continued uncertainty in the process for Clinical Commissioning Groups (CCGs) gaining NHS authorisation and budgetary control from Primary Care Trusts
Healthcare Locums PLC : HCL Permanent offer solution to UK’s spiralling birth rate 01/24/2013| 08:25am US/Eastern London, Tuesday 22 January, 2013 -Hospitals are struggling to cope with the sheer volume of expectant mothers as the UK experiences its highest birth rate in over 40 years. HCL Permanent Managing Director Stephen Hockey says the shortage of trained and qualified maternity services staff and midwifes within the NHS is a serious, ongoing issue that needs immediate address. "As an organisation, we understand the pressure trusts are under to source the right staff to cope with sheer demand under current budget constraints. As a solution, HCL Permanent is currently sourcing qualified maternity services staff and midwives from Europe to fill permanent posts in hospitals in the UK." Mr Hockey said. "By utilising HCL Permanent, trusts are able to use their internal resources where they are most needed - frontline patient care. It also reduces spend on agency staff and increases retention." He said. Stephen Hockey CEO HCL Social Care Released today, the State of Maternity Services Report outlines the extent of issue, with RCM Chief Executive Cathy Warwick stating England alone has a shortfall of 5000 midwives, and that 'anxiety and concern' continues to surround the current shortage. The Office for National Statistics (ONS) projects the UK birth rate could reach 743,000 by 2014, an increase of 8% on 2011 figures. Notably, the highest rise was amongst women aged 40, a group more likely to require medical intervention. "Providing stability to trusts and continuity of patient care is core to our business model. Our European maternity services staff and midwives undergo vigorous screening, training and in-depth compliancy checks so we can stand behind each placement we make." For any further information, contact HCL Communications and PR Manager Laura Ackland on +44 (0) 207 451 1448. About HCL plc HCL plc, headquartered in London, was formed in 2003 and is a leading provider of staffing solutions in the health and social care sectors within our chosen markets. HCL supply over 2,000 temporary and permanent doctors, nurses, allied health professionals, qualified social workers and administration & clerical staff to public and private sectors every week. We are an international company with offices in UK and Australia and recruitment drives in Europe.www.hclplc.com, view our facebook page or follow us on twitter @HCLplc
Avia Health Infrmtcs Trading Statement RNS Number : 3366W Avia Health Informatics PLC 24 January 2013  Avia Health Informatics Plc ("Avia" or "the Company") Trading update On 27 November 2012, the Company announced that "the challenging market conditions in our core UK markets may continue to restrain growth in the near term. Delays in the government health policy on CCGs have impacted the expected growth in sales of the PathFinderRF product…" Avia announces that, notwithstanding strong demand from customers for its PathFinderRF software, due to further delays caused by continued uncertainty in the process for Clinical Commissioning Groups (CCGs) gaining NHS authorisation and budgetary control from Primary Care Trusts, it experienced a significant shortfall in anticipated revenues in December 2012. This led to a consequent reduction in anticipated cash inflows. In response to that, the Company has been in contact with its principal creditor which has adopted a flexible and supportive approach and agreed to a deferral of amounts owed. The Directors believe that this agreement, together with the implementation of other cost reduction and deferral measures, will enable the Company to successfully weather the current difficult market conditions. Whilst the Directors anticipate that the trading environment will remain challenging up until the anticipated completion of the CCG transition process on 1st April 2013, they are pleased to report that trading in January has been ahead of expectations and that the order book and order pipeline are encouraging and anticipate that the Company will be able to make positive announcements regarding further contract wins in the coming weeks.
While the Group has met its 30 December 2012 banking covenant tests, having updated its forecasts and projections to reflect the current trading conditions, the Board has identified that in order to deliver these projections there is likely to be a requirement for additional capital funding in the next 12 months. The forecasts also indicate that the financial covenants for March and June 2013 may not be met. The Company is in constructive negotiations with its banking partners regarding resetting the covenants for 2013 and the Company believes that the banks remain supportive of the business. The Board is exploring a number of options to safeguard the strategy of the business, including ways in which to further reduce the Group's cost base and improve its profitability. The Board remains convinced that the Company is pursuing the correct strategy and is considering all options for the best way forward and the options regarding access to additional capital for the Company. In this regard the Board has approached its two substantial shareholders to ascertain their appetite to provide additional capital to the Company and, while these discussions are on-going, they have indicated that they are supportive of the business going forward. However, no guarantee can be provided until the Company is able to ascertain the quantum of the fundraising needed and any terms on which such fundraising could be undertaken. A further update will be made in due course.
Healthcare Locums Company update RNS Number : 2033W Healthcare Locums PLC 23 January 2013  Healthcare Locums plc ("HCL" or the "Company") Company Update The Board of Healthcare Locums plc, a leading provider of staffing solutions in the health and social care sectors provides the following update for the 52 weeks ended 30 December 2012. On 28 September 2012 the Company announced its interim results for the 26 weeks ending 1 July 2012 (the "Interims"), which highlighted the key issues facing the business. The Company had suffered difficult trading conditions in both of its two geographic markets, the UK and Australia. In addition, and as a result of the poor trading conditions, the Company had agreed with its lending banks that they would reset covenants and defer the start of the repayment of the loan principal until June 2013. Since that date, trading has continued to be difficult. In particular: · In the UK, delays in NHS framework renewals have continued to constrain the Group's ability to capitalise on its strategy of moving to higher volume lower margin framework contracts in the UK. This uncertainty is expected to continue into 2013. This has depressed the performance of both the Doctors and Allied Health Professional divisions. In the second half, the Nursing division successfully implemented a new IT system, however this necessary diversion delayed the business's ability to capitalise on the significant demand in this market and impacted its short term results. Further, the Social Care division has remained under margin pressure as Local Authorities continue to reduce budgets; · In Australia, weakness in demand in the private and public sectors has continued as the macro economy has deteriorated. Although the Company has made senior management changes and placed a renewed focus on key public sector clients, the current uncertainties in demand make Australia a challenging market in which to operate and as a result revenues have been impacted in the second half of the year; · The Company continues to be involved in litigation: o the first, regarding the former Executive Vice Chairman Kate Bleasdale; and o the second, in respect of US based proceedings against the Company. Since the Interims there have been no further material developments with respect to this litigation other than the initial rejection of Ms Bleasdale's application for an appeal. As allowed in such an instance, Ms Bleasdale has requested a hearing in front of a Judge to challenge this decision. The Board remains confident of its defence in both claims and will strenuously defend its position. At 30 December 2012, the Group had A$60m (£39m) of term bank loans and £9m cash at bank. While the Group has met its 30 December 2012 banking covenant tests, having updated its forecasts and projections to reflect the current trading conditions, t
I'll go and watch the traffic lights change - a tad more exciting pursuit ..................
paint has dried......
Pace PLC Potential acquisition of Google's Motorola Home RNS Number : 9947T Pace PLC 20 December 2012  Pace plc Statement re potential acquisition of Google's Motorola Home business Pace plc ("Pace" or "the Company") notes the announcement from Google that it has reached agreement to sell its Motorola Home business. The Company was unable to reach an agreement with Google on terms that the Board believes would have been in the interests of Pace's shareholders. Accordingly, Pace has contacted the Financial Services Authority to request that the suspension of its securities from the Official List is lifted without delay. Pace expects the suspension to be lifted shortly. Mike Pulli, Chief Executive Officer of Pace, said: "We have made significant progress in developing our business over the past 12 months by being relentless in pursuing the strategy we announced in November 2011. That strategy is to transform our core economics, build on our position as the global leader in PayTV hardware and widen out our business into software, services and integrated solutions. We viewed the potential acquisition of Google's Motorola Home business as an opportunity to accelerate our stated strategy, but only if real shareholder value could be delivered. Although we had the support of our major shareholders and committed facilities, we could not reach an appropriate conclusion to the potential transaction. We remain confident in our 2012 financial results as recently stated in our Interim Management Statement on 14 November. We look forward to making a Trading Update to the market on 10 January to provide further detail of the progress we have made during the year, and continue to be encouraged about our prospects for the future."
The Group has made a positive start to the second half of this financial year. Bglobal Metering has been appointed as Dual Energy's preferred smart meter partner and increased installation volumes are expected to flow as a result. Utiligroup has brought two more companies into the market as energy suppliers through its "Supplier in a Box™" product, including DONG Energy one of the leading energy groups in Northern Europe with an increasingly integrated energy portfolio in the UK. It was expected that these contracts would complete prior to the end of September but they were only completed in the last couple of weeks and as a result Utiligroup is now performing in line with the Board's expectations. The Group has continued to focus on delivering a dual fuel SMETS compliant offering alongside investment in its Smart Meter Services Platform that can offer customers a complete end-to-end smart meter solution. Following the acquisition of Draig Technology Limited in September 2012, which provides billing and CRM software to independent electricity suppliers, the Group has continued to develop a Smart Pay As You Go ("PAYG") integrated software solution for both new entrants and existing supply companies, which allows the Group to offer a complete "meter to cash" solution. Investment has also been made in establishing Bsmart Energy Solutions, a company that is focused on delivering end to end energy services to the SME market and in the creation of Nutech Training Limited, a company that provides dual fuel smart meter installation training. Encouragingly, we are in advanced discussions with a number of independent energy suppliers regarding the delivery of our Smart Meter Services Platform, which will provide significant meter volume and associated software and services sales for the Group. We are also seeing substantial interest in our energy services offering and have now assembled a team at Bsmart that is capable of delivering substantial value for the Group. This includes working alongside a number of local authorities to bring our extended services proposition to the community energy market. The Board looks forward to updating shareholders on these strategic developments at the time of the interim results in early December.